Literature DB >> 1282913

Characterization of normal breast epithelial cells in primary cultures: differentiation and growth factor receptors studies.

P Berthon1, G Pancino, P de Cremoux, A Roseto, C Gespach, F Calvo.   

Abstract

The growth and differentiation of normal human mammary epithelial cells (HMEC) were studied after propagation of serial cultures from breast tissue biopsies from 42 mammoplasty patients. Cells were grown for up to 7 mo. in low calcium medium. HMEC cultures displayed heterogeneous growth patterns, according to the average doubling time of 44 +/- 6 h for 32 generations. Proliferation peaked at Day 30. HMEC maintained a normal karyotype and were organized in ductlike structures when cultured in collagen gel matrix. The cultures retained several phenotype traits of the epithelial lineage, including the expression of cytokeratins 18 and 19, specific mammary gland antigens, as shown by indirect HMEC immunostaining by the monoclonal antibodies DF3, EMA, 7B10, and 1BE12. Estrogen receptors were undetectable, whereas progesterone receptors were present at very low density. High-affinity cell surface receptors for epidermal growth factor (EGF) (Kd = 1.1 x 10(-10) M) were observed at a density of 50,000 to 100,000 sites per cell. Accordingly, [3H]thymidine incorporation in HMEC was optimally stimulated by EGF at concentrations of 10(-11) to 10(-10) M. HMEC were also seen to possess functional VIP receptors linked to the adenylate cyclase system, as we previously observed in seven human breast cancer cell lines. These results show that long-term cultures of HMEC provide useful models for studying the growth and differentiation of the normal human mammary gland, and the role of growth factors and hormones in these functions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1282913     DOI: 10.1007/BF02631059

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  63 in total

1.  Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.

Authors:  R Moll; T Achtstätter; E Becht; J Balcarova-Ständer; M Ittensohn; W W Franke
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

2.  Transforming growth factor alpha production and epidermal growth factor receptor expression in normal and oncogene transformed human mammary epithelial cells.

Authors:  E M Valverius; S E Bates; M R Stampfer; R Clark; F McCormick; D S Salomon; M E Lippman; R B Dickson
Journal:  Mol Endocrinol       Date:  1989-01

3.  A rapid banding technique for human chromosomes.

Authors:  M Seabright
Journal:  Lancet       Date:  1971-10-30       Impact factor: 79.321

4.  Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells.

Authors:  D Zajchowski; V Band; N Pauzie; A Tager; M Stampfer; R Sager
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

5.  Tamoxifen and hydroxytamoxifen isomers versus estradiol effects on normal human breast cells in culture.

Authors:  C Malet; A Gompel; P Spritzer; N Bricout; H Yaneva; I Mowszowicz; F Kuttenn; P Mauvais-Jarvis
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

6.  Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.

Authors:  C Gespach; W Bawab; P de Cremoux; F Calvo
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

7.  Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins.

Authors:  L C Murphy; L J Murphy; D Dubik; G I Bell; R P Shiu
Journal:  Cancer Res       Date:  1988-08-15       Impact factor: 12.701

8.  Sustained growth and three-dimensional organization of primary mammary tumor epithelial cells embedded in collagen gels.

Authors:  J Yang; J Richards; P Bowman; R Guzman; J Enami; K McCormick; S Hamamoto; D Pitelka; S Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

Review 9.  Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts.

Authors:  M F Greaves; G Hariri; R A Newman; D R Sutherland; M A Ritter; J Ritz
Journal:  Blood       Date:  1983-04       Impact factor: 22.113

10.  Epithelial membrane antigen: partial purification, assay and properties.

Authors:  M G Ormerod; K Steele; J H Westwood; M N Mazzini
Journal:  Br J Cancer       Date:  1983-10       Impact factor: 7.640

View more
  8 in total

1.  Fidelity of the methylation pattern and its variation in the genome.

Authors:  Toshikazu Ushijima; Naoko Watanabe; Eriko Okochi; Atsushi Kaneda; Takashi Sugimura; Kazuaki Miyamoto
Journal:  Genome Res       Date:  2003-05       Impact factor: 9.043

Review 2.  Myoepithelial cells: pathology, cell separation and markers of myoepithelial differentiation.

Authors:  Catherine Clarke; Jennifer Sandle; Sunil R Lakhani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-07       Impact factor: 2.673

3.  Estimating doubling time of cells in vitro.

Authors:  D K Kim
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-06       Impact factor: 2.416

4.  Statistical methods for estimating doubling time in in vitro cell growth.

Authors:  D K Kim
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-04       Impact factor: 2.723

Review 5.  EGF receptor expression, regulation, and function in breast cancer.

Authors:  S A Chrysogelos; R B Dickson
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

6.  Biodistribution of iodine-125 tyramine transforming growth factor alpha antisense oligonucleotide in athymic mice with a human mammary tumour xenograft following intratumoral injection.

Authors:  S Cammilleri; S Sangrajrang; B Perdereau; F Brixy; F Calvo; H Bazin; H Magdelenat
Journal:  Eur J Nucl Med       Date:  1996-04

7.  Transforming growth factor beta 1 and sodium butyrate differentially modulate urokinase plasminogen activator and plasminogen activator inhibitor-1 in human breast normal and cancer cells.

Authors:  X Dong-Le Bourhis; V Lambrecht; B Boilly
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

8.  Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes.

Authors:  Karin Zins; Gerwin Heller; Mathias Mayerhofer; Martin Schreiber; Dietmar Abraham
Journal:  Oncotarget       Date:  2018-05-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.